The global minimally invasive surgery market is projected to grow from USD 94.45 billion in 2025 to USD 199.30 billion by 2030 at a 16.1% compound annual growth rate, according to MarketsandMarkets, driven by rising demand for smaller-incision procedures, advances in robotic-assisted surgery, AI-enabled imaging, 3D visualization, and broader outpatient adoption. In a related diagnostic segment, DelveInsight said the global fusion biopsy market was about USD 798 million in 2025 and could reach about USD 1.5 billion by 2034, supported by rising prostate cancer prevalence, wider use of mpMRI-targeted biopsy, and MRI-ultrasound fusion systems intended to improve lesion targeting and reduce unnecessary biopsies. MarketsandMarkets said Asia Pacific is expected to be the fastest-growing region in minimally invasive surgery, with imaging and visualization systems and urological surgery leading growth, while DelveInsight said North America held a 42.67% share of the fusion biopsy market in 2025 and accessories were the largest product segment.